That will hopefully continue to lower prices," said Levin-Scherz
Medicare patients will benefit from a $50 copay structure beginning mid-2026 under new government agreements
Running distance was monitored using a Sigma Pure 1 Topline 2016 computer (Sigma Sports) and, after 1 week of habituation, daily running distance was monitored for 3 days
Multiple drugs within this class have been approved for T2D management since the mid-2000s
The analysts in a Tuesday note caveated that China-specific trials tend to generate less profound weight loss relative to global studies, primarily driven by lower BMI and higher proportion of male participants (though we recognize that the proportion of females was similar between HARBOR-1 and ATTAIN-1). After this data drop, Hengrui said it plans on submitting new drug applications (NDAs) in both obesity and type 2 diabetes in China, according to a Tuesday release
Final Thoughts Medicaid GLP-1 coverage in 2026 breaks down cleanly: diabetes is covered everywhere, cardiovascular disease and sleep apnea indications are covered most places, and obesity treatment remains a patchwork